Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2026-02-03 @ 5:51 AM
Study NCT ID:
NCT00553358
Status:
COMPLETED
Last Update Posted:
2021-09-21
First Post:
2007-11-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-01-05
Start Date Type:
ACTUAL
Primary Completion Date:
2010-05-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-23
Completion Date Type:
ACTUAL
First Submit Date:
2007-11-01
First Submit QC Date:
None
Study First Post Date:
2007-11-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-05-26
Results First Submit QC Date:
None
Results First Post Date:
2011-10-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-24
Last Update Post Date:
2021-09-21
Last Update Post Date Type:
ACTUAL